Search for: "Beck/Herrmann"
Results 121 - 140
of 270
Sort by Relevance
|
Sort by Date
29 Dec 2008, 5:00 am
This work is entirely Pearson's; neither Beck nor Herrmann had anything to do with it:The belief that polar bears cover their black noses with a paw to camouflage themselves in the snow and ice while hunting has been generally discredited. [read post]
17 Dec 2008, 2:37 pm
Beck & Herrmann have been hearing things through the grapevine about those controversial proposals from the Financial Accounting Standards Board (FAS) to require more disclosures of potential lawsuit exposures from publicly traded companies. [read post]
16 Dec 2008, 2:35 pm
Remember: Beck and Herrmann -- Vote for us and nobody gets hurt. [read post]
11 Dec 2008, 9:03 am
Beck and Herrmann at Drug and Device Law are mostly right: What, our reader asked, should companies do to minimize the risk that they become embroiled in a mass tort? [read post]
6 Dec 2008, 5:27 pm
Beck/Herrmann at Drug and Device Law briefly reject the litigation relevance of legislation until it's passed. [read post]
5 Dec 2008, 5:25 am
Now Beck and Herrmann help fill the gap. [read post]
5 Dec 2008, 4:15 am
Beck/Hermann of Drug and Device Law summarize a letter from John Beisner (O'Melveny) commenting on the new ALI Draft Principles of Aggregate Litigation. [read post]
4 Dec 2008, 12:17 pm
Beck and Herrmann: Initially, we'd invite anybody who doesn't think that plaintiffs in product liability litigation aren't asking state courts to ignore FDA decisions to read the statements of fact in either of these briefs. [read post]
1 Dec 2008, 10:00 pm
Seasoned defense lawyers Jim Beck of Philadelphia and Mark Herrmann of Chicago, along with authoritative guest contributors, pick apart rulings and explore issues common to this niche practice.Those guys have stiff competition when you see the niche category with 15 entrants -- tough competition because they want people to vote. [read post]
1 Dec 2008, 4:14 pm
Beck is an attorney with Dechert LLP, while Herrmann works as a partner for Jones Day. [read post]
14 Nov 2008, 5:34 am
"Truly awful" policy consequences of unprecedented decision by California court to hold brand-name drug company liable for injury caused by generic version of drug [Beck & Herrmann] Upstate appeals court dismisses suit by New York judges demanding pay raise... [read post]
10 Nov 2008, 11:20 am
According to an on-line story that appeared today in LAW.COM, Product liability attorneys Mark Herrmann (Jones Day in Chicago) and James Beck (Dechert in Philadelphia) responded quickly by stating that the ruling “stands product liability law on its head. [read post]
4 Nov 2008, 7:59 pm
Beck and Herrmann are your one-stop resource for coverage of the drug pre-emption case, and I'm not even going to try to compete with them. [read post]
31 Oct 2008, 2:19 pm
Beck and Herrmann give it a much deserved skewering (more skewering from former FDA official Sheldon Bradshaw at American Lawyer; and background). [read post]
31 Oct 2008, 10:19 am
Beck/Herrmann at Drug and Device Law with a post title that should draw you in: A Halloween Special: Bodysnatchers! [read post]
21 Oct 2008, 7:54 pm
Over at Drug and Device Law Beck and Herrmann muse on the possible impact of a win by Sen. [read post]
20 Oct 2008, 6:47 pm
Beck and Herrmann have more, including links to the agenda (PDF) and the Summit's website.... [read post]
13 Oct 2008, 5:12 pm
If you want to keep up with what's happening in federal preemption jurisprudence, the best place is the Drug and Device Law blog of Jim Beck (Deckert LLP, Philadelphia) and Mark Herrmann (Jones Day, Chicago). [read post]
3 Oct 2008, 10:53 am
Several stories and updates that are worth a mention, but do not warrant a separate post: I was going to write a post explaining new Federal Rule of Evidence 502, but Beck & Herrmann at Drug & Device Law beat me to it and did an excellent job (actually, they did not, but their colleague David B. [read post]
3 Oct 2008, 5:04 am
Because even if you're not interested in drug-and-device-specific topics like the learned intermediary rule and the controversy over compulsory provision of experimental drugs to terminal patients, you may still benefit by learning about such wider topics as the difference between... [read post]
